about
In silico prediction of Gallibacterium anatis pan-immunogensPost-Genomics and Vaccine Improvement for LeishmaniaGroup B Streptococcus vaccine: state of the artApproaches to vaccines against Orientia tsutsugamushiIntroduction of a disulfide bond leads to stabilization and crystallization of a ricin immunogenAnaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics ApproachThe Capricious Nature of Bacterial Pathogens: Phasevarions and Vaccine DevelopmentThe key role of genomics in modern vaccine and drug design for emerging infectious diseasesTrends in population-based studies of human genetics in infectious diseasesPooled protein immunization for identification of cell surface antigens in Streptococcus sanguinisCharacterization of single chain antibody targets through yeast two hybridA conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.Scaffolding to build a rational vaccine design strategy.T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.Plasmodium immunomics.The Corynebacterium pseudotuberculosis in silico predicted pan-exoproteomeAn assessment on epitope prediction methods for protozoa genomes.The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse VaccinologyCharacterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections.Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age.The importance of animal models in tuberculosis vaccine development.Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigensSex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccineComputer-aided antibody design.VacSol: a high throughput in silico pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinology.Cooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli.Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactionsThe potential impact of vaccination on the prevalence of gonorrhea.The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approachesPre-erythrocytic malaria vaccines: identifying the targets.Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.Vaccine development against Neisseria meningitidis.A decade of molecular pathogenomic analysis of group A Streptococcus.Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.Future prospects for new vaccines against sexually transmitted infections.Cellular interactions by LPxTG-anchored pneumococcal adhesins and their streptococcal homologues.Genome-wide association studies and susceptibility to infectious diseases.
P2860
Q21146619-5E07B645-04A8-48BF-A2ED-EB33A84BFBDFQ26752532-ACD50991-AE23-4D58-A8F6-02E5F4E07511Q26796438-BC393904-3357-4F84-945E-B2AD6856246FQ26849239-6E836654-3375-4913-85C9-F3160D31935CQ27667224-47A06338-A347-498D-87E1-8F5973A364BBQ28074461-B1E87DFC-7F52-4695-A164-A9D327628BACQ28074750-7062D899-FCFC-40EC-BC3A-F9F99EEE03FCQ28476274-3B506439-9F8A-4751-83B6-CEEEDF8AD999Q28732216-F41D8343-97C4-4EA7-9C5B-BD7175209367Q33644475-7B09A1CA-F681-4CD0-925D-3F74FB57CC56Q33667675-DF702026-2810-4E00-8C5A-09E759EA00A3Q34121681-A4EB3524-B755-4718-B789-D019AA612D0AQ34155231-57268B20-C681-4EEA-943B-52824CBAD1FBQ34241394-7E63A9BE-E5A7-4780-95E7-9BDC24D57F6FQ34312495-EB2703C9-B0A9-47C0-A721-CEA85CACAF13Q34419934-85DA6037-309B-4A77-AE86-2E49CCEC475BQ34457376-825B2074-A403-4C0B-8944-2217A47F80B0Q34484256-2FD08DAB-BB85-4B3A-87A9-12538227E608Q35191903-7C871D06-0C77-44A5-8403-051DA0D603F8Q35549821-A3BB7F09-4C9B-415D-B076-C3759B78040FQ35760241-1324A218-9E3F-4006-B7CF-6626B172D2E7Q35889270-0C94E1A6-A0CA-4124-9441-8609A23D06B4Q35895817-D7C56CB9-0D10-4280-ADC7-29F51392D94AQ36060914-10301359-AC15-4D59-9FC3-3F44790E3DD5Q36090390-AC2D05A1-76A1-43BC-88EE-257DA9FC4A0FQ36254449-8694F077-4ABD-409E-BE34-9D180BC4807FQ36278990-D59D936B-0901-496C-A952-6B458DE05CF9Q36362257-64796E23-AD71-402F-A763-F5E62BCBAF64Q36506158-5AD8F814-2A55-44CF-97E2-9F37EFF484FEQ36551134-E7830EC2-546B-494F-8D7D-E058AB5299D8Q36603325-2E43205F-6ECA-4AAB-BD8C-17B8E626802BQ36644236-2044007B-74EE-4E84-831F-5B9B7909319CQ37119456-5DC95D3B-32C7-4A67-85CC-5EE166C71FD6Q37120976-132471DC-8122-4F73-8719-DD2B7DACA6B8Q37274707-346B4AAC-1988-410F-9929-BC88457258B2Q37328487-57063C9D-A27D-492C-AF8D-F3A478EDB718Q37581984-F4E2C894-3C11-4EDA-91D3-9B7E4ABCE27DQ37665012-D1156B53-9F38-4B2A-811F-8CB04942B174Q37825598-E35A862A-795C-44B3-B208-B6DA003789FDQ37857571-98AE6619-85E5-4D4C-8B2E-309373A799C6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccinology in the genome era.
@en
Vaccinology in the genome era.
@nl
type
label
Vaccinology in the genome era.
@en
Vaccinology in the genome era.
@nl
prefLabel
Vaccinology in the genome era.
@en
Vaccinology in the genome era.
@nl
P2860
P356
P1476
Vaccinology in the genome era.
@en
P2093
C Daniela Rinaudo
Kate L Seib
P2860
P304
P356
10.1172/JCI38330
P407
P577
2009-09-01T00:00:00Z